UNIVERSITE PARIS DESCARTES;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6);CENTRE NATIONAL DE LA R;ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
发明人:
DUPIN, NICOLAS,MARCELIN, ANNE-GENEVIEVE,CALVEZ, VINCENT,GRANGE, PHILIPPE
申请号：
CA3029012
公开号：
CA3029012A1
申请日:
2017.06.28
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to compounds of the following general formula (I) or (II) or a pharmaceutically acceptable salt and/or solvate thereof, for use in the prevention and/or the treatment of disorders associated to gammaherpesvirinae, in particular to the human herpesvirus 8 (HHV8) or the human herpes virus 4 (HHV4), and pharmaceutical compositions containing such compounds.
